PharmaEngine announces the board resolutions on approving the Full Year of 2021 consolidated financial report.
· Issued by PharmaEngine, Inc.
Close
Today's Information
Provided by: PharmaEngine, Inc.
SEQ_NO
8
Date of announcement
2022/03/08
Time of announcement
18:10:57
Subject
PharmaEngine Company announces the board
resolutions on approving the Full Year of 2021
consolidated financial report.
Date of events
2022/03/08
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/03/08
2.Date of the audit committee approved:2022/03/08
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):654,835
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):617,762
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):362,689
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):545,395
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):426,031
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):426,031
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):2.95
11.Total assets end of the period (thousand NTD):4,026,343
12.Total liabilities end of the period
(thousand NTD):87,705
13.Equity attributable to owners of parent end of the
period (thousand NTD):3,938,638
14.Any other matters that need to be specified:None
